News - Kyowa Hakko Kirin, Nephrology and Hepatology

Filter

Popular Filters

Kyowa Hakko drops Ph II study of bardoxolone

11-11-2013

Japanese drugmaker Kyowa Hakko Kirin says it is discontinuing its Phase II clinical studies evaluating…

DiabetesKyowa Hakko KirinNephrology and HepatologyPharmaceuticalReata PharmaceuticalsResearch

Back to top